1. Home
  2. ETON vs NGS Comparison

ETON vs NGS Comparison

Compare ETON & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • NGS
  • Stock Information
  • Founded
  • ETON 2017
  • NGS 1998
  • Country
  • ETON United States
  • NGS United States
  • Employees
  • ETON N/A
  • NGS N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • NGS Oilfield Services/Equipment
  • Sector
  • ETON Health Care
  • NGS Energy
  • Exchange
  • ETON Nasdaq
  • NGS Nasdaq
  • Market Cap
  • ETON 329.8M
  • NGS 282.3M
  • IPO Year
  • ETON 2018
  • NGS 2002
  • Fundamental
  • Price
  • ETON $14.68
  • NGS $21.85
  • Analyst Decision
  • ETON Strong Buy
  • NGS Strong Buy
  • Analyst Count
  • ETON 3
  • NGS 2
  • Target Price
  • ETON $24.00
  • NGS $26.50
  • AVG Volume (30 Days)
  • ETON 270.3K
  • NGS 67.3K
  • Earning Date
  • ETON 03-18-2025
  • NGS 03-17-2025
  • Dividend Yield
  • ETON N/A
  • NGS N/A
  • EPS Growth
  • ETON N/A
  • NGS 260.53
  • EPS
  • ETON N/A
  • NGS 1.37
  • Revenue
  • ETON $39,011,000.00
  • NGS $156,742,000.00
  • Revenue This Year
  • ETON $22.19
  • NGS $30.81
  • Revenue Next Year
  • ETON $109.55
  • NGS $13.48
  • P/E Ratio
  • ETON N/A
  • NGS $15.96
  • Revenue Growth
  • ETON 23.29
  • NGS 29.36
  • 52 Week Low
  • ETON $3.03
  • NGS $16.70
  • 52 Week High
  • ETON $18.41
  • NGS $29.74
  • Technical
  • Relative Strength Index (RSI)
  • ETON 47.04
  • NGS 38.26
  • Support Level
  • ETON $14.28
  • NGS $20.22
  • Resistance Level
  • ETON $15.73
  • NGS $23.78
  • Average True Range (ATR)
  • ETON 1.02
  • NGS 1.20
  • MACD
  • ETON 0.03
  • NGS -0.01
  • Stochastic Oscillator
  • ETON 55.23
  • NGS 28.95

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: